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Cytotoxic T  lymphocytes (CTL) have been implicated as effectors in allograft 
rejection and  in  control  of viral  infection.  Induction of a  cytolytic response 
requires T  cell recognition of foreign major histocompatibility complex (MHC) 
class I glycoproteins, or syngeneic MHC antigens along with a foreign (i.e., viral) 
protein.  This recognition process  leads to proliferation and differentiation of 
precursor cells to effector CTL capable of lysing target cells that bear the same 
antigens. While class  I  oligosaccharide residues do not contribute to serologic 
determinants (1-4) their role in T  cell recognition has remained unclear. Modi- 
fication of the carbohydrates of membrane glycoproteins on intact stimulating 
or target cells has been observed to inhibit (1,  5, 6), stimulate (7,  8), or have no 
effect (2, 6, 9) on T  cell responses. In all of these cases, it is difficult to conclude 
whether the observed effects were due to altered MHC antigen oligosaccharides, 
since modifications could not be limited to the surface glycoprotein of interest, 
and the extent of modification could not be readily determined. 
Class  I  antigens of the  murine  MHC (H-2)  are  polymorphic two-chain cell 
surface glycoproteins consisting of a  glycosylated transmembrane heavy chain 
(Mr  40,000-50,000)  noncovalently associated with /32-microglobulin, an invar- 
iant, nonglycosylated polypeptide (Mr  1 1,500).  Amino acid and DNA sequence 
data suggest that the extracellular portion of the heavy chain can be divided into 
three globular domains of ~91  amino acids each (~, c~z, and as).  Determinants 
recognized by T  cells appear to reside in the c~l and a2 domains (10),  regions of 
maximal amino acid variability (11).  Glycosyl moieties are also present in these 
regions, N-linked to asparagine residues at positions 86 and 176.  A third glycan 
attachment site in K  d, D b, and L  d antigens is at residue 256 (11). 
Purified class I alloantigen in artificial membranes (liposomes) can stimulate a 
CTL response of comparable magnitude to that obtained using intact stimulating 
cells when added to in vitro cultures of spleen cells from mice previously primed 
to the same alloantigen (12).  The magnitude of the response to the liposomes 
provides a direct measure of the effectiveness of antigen recognition by primed 
This work was supported by grant CA-147723 from the National Institutes of Health, Bethesda, 
MD. Address correspondence to M. Mescher, Medical Biology  Institute, 11077 North Torrey Pines 
Road, LaJolla, CA 92037. 
J. ExP. MEt). © The Rockefeller  University  Press • 0022-1007/85/10/1381/06 $1.00  1  381 
Volume 162  October 1985  1381-1386 1382  GOLDSTEIN  AND  MESCHER  BRIEF  DEFINITIVE  REPORT 
precursor  CTL  (pCTL),  provided  that  an  optimum  amount  of  interleukin- 
containing  supernatant  is  added  (12).  This  approach  has  made  it  possible  to 
examine the role of the carbohydrate moieties in class I  MHC recognition. 
Materials and Methods 
Mice and  Tumor Cells.  (BALB/c ×  DBA/2)F~  (CD2F1)  (H-2  d) mice were purchased 
from Cumberland View Farms, Clinton, TN. (AKR ×  DBA/2)FI (AKD2F1) (H-2  kxd) and 
A/J (H-2  ") were purchased from The Jackson Laboratory, Bar Harbor, ME. RDM-4 (H- 
2k), an AKR lymphoma, and P815 (H-2d), a mastocytoma of DBA/2 origin, were main- 
tained by intraperitoneal passage as ascites in AKD2F~ mice. 
Put,cation of Native and RadiolabeUed H-2K k.  H-2K  k was purified from RDM-4 ascites 
cell detergent lysates by affinity chromatography on an 11-4.1 monoclonal antibody (mAb) 
column (12) with a yield of 0.9 mg H-2K  k per  101° cells.  Internally radiolabeled H-2K  ~ 
was purified from RDM-4 cells cultured in glucose- or methionine-deficient RPMI  1640 
(Gibco Laboratories, Grand Island, NY) with [SH]mannose or [sSS]methionine,  and 5% 
dialyzed fetal calf serum. 125I-H-2Kk  was prepared by reacting 10 #g purified antigen with 
0.5  mCi  Nal~SI and two Iodobeads (Pierce Chemical Corp.,  Rockford, IL) in  0.15  ml 
0.5% deoxycholate for 30 rain at 4°C, and isolated by Sephadex G-25 chromatography 
and dialysis, yielding a product with a specific activity of 400 cpm/ng ~rotein. 
Preparation  of Liposomes  and Deglycosylated  H-2K  k.  Purified H-2K  was incorporated 
into unilamellar liposomes by mixing with lipid (1 #g H-2K  k per 10 nmol phospholipid) in 
0.5% deoxycholate, followed by dialysis to remove the detergent (12).  Liposomes were 
harvested by centrifugation at 100,000 g for 60 rain, and resuspended in 33 mM EDTA, 
10 mM  Tris maleate,  170 mM  NaC1, pH  6.1.  Liposomes containing 5 #g H-2K  k were 
subjected to either limited (1 U enzyme for 4 h) or exhaustive (4 U for 21 h) endoglyco- 
sidase  F  treatment (endo F)  (EC-3.2.1;  New England  Nuclear,  Boston,  MA)  at  37°C. 
Controls without enzyme were incubated in parallel at 4°C and 37°C.  In some experi- 
ments, liposomes were reisolated from the enzymatic reaction mixture by centrifugation. 
All  H-2K  k preparations  were analyzed by  sodium  dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) on 5-15% slab gels. 
Effector  CTL Generation and Cytotoxicity.  Liposomes were added to responder spleno- 
cytes fiom CD2FI mice primed 2-4 mo previously by intraperitoneal injection of 2 ×  107 
RDM-4 cells, and cultured in 2 ml of medium with 7 ×  106 cells/well (Linbro Chemical 
Co.,  Hamden, CT) at  37°C and  5%  COs.  An optimal concentration of an  (NH4)2SO4 
fraction of supernatant fluid from rat spleen cells incubated with concanavalin A (I 2) was 
added at 22 h of culture. After 5 d, the cultures were assayed for cytotoxicity at several 
effector/target cell ratios by triplicate determination of the 5~Cr released in 4 h from 1.5 
x  104 labelled RDM-4 target cells incubated at 37°C.  Medium was RPMI  1640 supple- 
mented as previously described (12). 
Results 
Endo F  was used to obtain deglycosylated H-2K  k.  This enzyme cleaves high- 
mannose and complex-type asparagine-linked glycans, leaving a  single N-acetyl- 
glucosamine  residue  attached  to  the  protein  (13).  The  glycan-bearing  heavy 
chain  of  native  H-2K  k  is  of  48,000 Mr  when  examined  by  SDS-PAGE  and 
autoradiography (Fig.  1,  lane  1).  In  contrast,  three heavy chain products were 
found  when  H-2K  k was  incorporated  into  liposomes  and  subjected  to  limited 
endo  F  treatment  (Fig.  l,  lane  2).  These had Mr  of 48,000,  corresponding to 
native  H-2K  k,  45,000,  and  42,000.  While the 48,000  and  45,000 Mr products 
were  bound  by  lentil  lectin-Sepharose,  the  42,000  product was  not  (data  not 
shown).  This  indicated  that  the  45,000  Mr  product  retained  one  of the  two 
original carbohydrate moieties, and  that  the 42,000 product was fully deglyco- 
sylated.  Tunicamycin treatment  of cells to inhibit lipid-dependent protein gly- 
cosylation  yields a  mixture  of H-2K  k beavy  chain  products,  including  a  fully 
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FIGURE  1.  Deglycosylation of H-2K  k.  Purified H-2K  k in liposomes was subjected to limited 
or complete deglycosylation by endo F (EF)  and analyzed by SDS-PAGE. Protein bands were 
visualized by autoradiography (1~51) or staining with Coomassie Blue (CB) and fluorography 
(SH). Liposomes  containing 5 #g of H-2K  k and 5 ×  I0  s cpm in 0.05 ml underwent the following 
endo F treatments: lane  1, no enzyme, 4 h, 37°C; lane 2,  1 U enzyme for 4 h, 37°C; lanes 3 
and 4, no enzyme, 21  h incubation at 4°C; lanes 5 and 6, no enzyme, 21  h, 37°C; lanes 7 and 
8, 4 U, 21  h, 37°C; lane 9, 1 U endo F without liposomes. 
Extensive endo F treatment of liposomes bearing H-2K  k resulted in complete 
conversion  of heavy  chains  to  the  42,000  Mr  product,  as  demonstrated  by 
Coomassie Blue staining after SDS-PAGE (Fig. 1, lane 7). Incubation ofliposomes 
for the same length of time at either 4°C (lane 3) or 37°C (lane 5) in the absence 
of enzyme resulted  in  no change in  the Mr of heavy chains.  The absence of 
oligosaccharides in the 42,000 M, product was confirmed by examination of H- 
2K  k  biosynthetically  labelled  with  [3H]mannose.  No  detectable  radioactivity 
remained associated with the 42,000 Mr product resulting from endo F treatment 
(Fig.  1, lane 8), while controls retained the labelled glycans (lanes 4 and 6). The 
observation that all heavy chains are deglycosylated confirms that the antigen is 
asymmetrically oriented on the external face of these sealed unilamellar vesicles. 
Treatment with endo F resulted in no change in the M, of/32-microglobulin 
(Fig.  1),  nor  in  its  association  with  heavy  chain,  as  assessed  by  radioactivity 
recovered from the bands in gels of deglycosylated 125I-H-2Kk. Serological activity 
detected by the  11-4.1  mAb was also unaffected, since immunoprecipitation of 
deglycosylated [35S]methionine-labelled H-2K  k was 92%  that  of native labelled 
antigen (data not shown). These observations are consistent with studies of H-2 
and HLA class I antigens indicating that carbohydrate groups do not affect heavy 
and light chain association (4),  or contribute to alloantigenic serologic determi- 
nants  (1-4).  In  fact,  blocking  glycosylation  does  not  prevent  synthesis  and 
expression of serologically active antigen at the cell surface (1, 4). 
The ability of pCTL to recognize and respond to native or deglycosylated H- 
2K  k on liposomes was assessed by measuring their maturation to effector CTL 
capable of lysing antigen-bearing target cells. Addition to cultures of liposomes 
bearing either native or deglycosylated H-2K  k resulted in strong and comparable 
responses (Fig. 2 A). No cytolytic response was obtained in the absence of antigen- 1384  GOLDSTEIN  AND  MESCHER  BRIEF  DEFINITIVE REPORT 
10o 
A 
~  4(3 
2() 
0.5  2  8  24 
Effector/Target  Ratio 
250 
-~ 200 
0 
150 
100 
B  j" 
1.0  2.0  3.0  4.0  5.0 
Picomoles  H-2K~/ml 
FIGURE 2.  A,  Precursor  CTL  recognition  of native  and  deglycosylated  H-2K k.  Immune 
recognition was assessed by the development of cytotoxicity  towards  5~Cr-labelled RDM-4 
target cells in cultures  of primed CD2FI responder splenocytes incubated  for 5 d with: (A) 
medium only; (O) 0.125 #g/ml native H-2K k in liposomes; (O) 0.125 •g/mt  deglycosylated H- 
2K  k in  liposomes;  (A)  0.75  U/ml  endo  F.  The  native  and  deglycosylated  H-2Kk-bearing 
liposome preparations added to these cultures  were analyzed in Fig. 1. Percent specific 5~Cr 
release  =  100 X (experimental  -  spontaneous SlCr release)/(total  releasable  -  spontaneous 
5'Cr release).  Spontaneous  release  was <:18% for all experiments.  B, Generation of effector 
CTL by increasing  doses of native  and deglycosylated  H-2K k. Liposomes were subjected  to 
exhaustive endo F treatment (4 U, 21 h, 37 °C), or parallel control incubations without enzyme 
at 4°C or 37°C; reisolated  from incubation  mixtures  by centrifugation,  and suspended  in 
medium for culture.  A trace of 2~51-H-2Kk was included in the liposome preparation to permit 
antigen  quantitation.  Endo F-treated liposomes were confirmed to bear only deglycosylated 
H-2K k by SDS-PAGE and autoradiography, while incubation in the absence of enzyme resulted 
in no change in the Mr of the heavy chain. Cytotoxicity was measured after CD2F~ responder 
splenocytes were cultured for 5 d with liposomes bearing: (@) deglycosylated H-2Kt; (A) native 
H-2K k (pretreated at 4°C); (O) native H-2K k (pretreated at 37°C).  1 pmol of native  H-2K t is 
equivalent to 0.048 ~g. Lytic units provide an estimate of the relative number of effector CTL 
in a population.  One lytic unit is defined as the number of cultured cells required to ]yse 50% 
of the target cells in the 4-h 5JCr release assay. 
bearing  liposomes,  nor after  addition  of endo  F  alone  to cells  in  culture  (Fig. 
2A).  Furthermore,  neither  the presence  (Fig.  2A) nor the absence (Fig.  2B) of 
the enzyme in cultures  with liposomes affected the level of response obtained  to 
either native or deglycosylated antigen. 
The  response  to native and deglycosylated H-2K  k was examined  over a  wide 
range  of antigen  concentrations  to rule  out the  possibility  that a  small  amount 
of native  H-2K  k remaining in the endo F-treated  samples might account for the 
observed stimulation.  The  deglycosylated antigen  was found to stimulate  some- 
what more efficiently over the entire dose range for the response (Fig. 2B). This 
augmentation was observed with four independent  preparations,  and may result 
from  decreased  repulsion  between  treated  liposomes  and  negatively  charged 
surfaces  of pCTL.  In  fact,  removal  of negatively  charged  sialic  acid  by  neur- 
aminidase  increases  target  cell  sensitivity  to CTL  (7,  8).  Stability  of the  H-2K  k 
molecule  in  either  its  native  or  deglycosylated state  is  underscored  by mainte- 
nance of immunogenicity despite overnight incubation at 37 °C. 
To rule out possible nonspecific mitogenic effects of the deglycosylated class I 
antigen,  the specificity of CTL  induction  and of the resulting effector cells was 
examined (data not shown). When splenocytes from A/J (H-2K  k) mice previously 
immunized  with  P815  (H-2K d)  cells  were  cultured  for  5  d  in  the  presence  of 
plasma  membranes  from  P815  cells,  effector  CTL  were  generated  that  lysed 
P815  but  not  RDM-4  targets.  Culture  of the same cells with  liposomes  bearing GOLDSTEIN  AND  MESCHER  BRIEF  DEFINITIVE  REPORT  1385 
either native or deglycosylated H-2K  k resulted in no response using either tumor 
cell target. These liposomes, at the same and lower concentrations,  stimulated a 
strong response by CD2FI spleen cells, and the resulting effectors were specific 
for target cells bearing the appropriate  H-2K  k alloantigen. 
Discussion 
Liposomes bearing completely deglycosylated H-2K  k have been shown in this 
report to trigger  the  maturation  of precursor to effector CTL as effectively as 
liposomes with native antigen.  It follows that class I oligosaccharide moieties do 
not contribute to alloantigenic determinants recognized by the majority of splenic 
pCTL. If a small number of pCTL can recognize determinants that include the 
carbohydrate, they constitute a minor portion of the aliogeneic response. These 
results also show that induction of the cytolytic response does not require non- 
antigen  specific  interaction  of H-2K  k glycan  moieties  with  either  the  T  cell 
receptor  or  accessory molecules.  A  role  for  carbohydrates  in  other  accessory 
interactions during target cell binding or lysis cannot be ruled out. 
Recently, site-directed mutagenesis was used to delete the oligosaccharide at 
position 86 in H-2L  d by substituting the original asparagine with a lysine residue, 
which is not glycosylated (14). Mouse L cell transfectants expressed the mutant 
product  and  were  recognized  by  H-2Ld-reactive  CTL.  However,  a  limited 
number of conclusions can be drawn from this report regarding the role of H-2 
oligosaccharides  in  T  cell  recognition.  Only  one  of the  three  carbohydrate 
residues  present  in  H-2L  d  was  removed.  Further,  as  noted  by  the  authors, 
mutagenesis not only removed the glycan at position 86, but substituted another 
amino acid, which may affect conformational changes unrelated to the absence 
of the oligosaccharide.  Finally,  while the use of liposomes allowed quantitative 
assessment of the functional effects of removing all the carbohydrate from native 
H-2K  k, the gene transfer results are qtialitative, as they are complicated by varied 
levels of antigen  expression  on  different  transfectants  and  by assumptions  re- 
garding the effect this might have on cytolysis by CTL. 
The use of purified MHC antigen in liposomes to assess structural requirements 
for T  cell recognition  provides several advantages over use of modified whole 
stimulator cells. The modification can be confined to the antigen of interest, and 
the  extent  of modification  can  be readily  determined.  Furthermore,  the  dose 
response to the antigen or its modified forms can be accurately quantitated.  The 
importance of this is indicated by the observation that removal of >90% of the 
H-2 from the surface of allogeneic cells by papain  treatment  did not decrease 
the CTL recognition of these cells (15). Thus, modification or removal of >90% 
of a critical antigen structure on intact cells can appear to have no effect. 
Summary 
The  ability  to  generate  specific  cytotoxic  responses  using  purified  major 
histocompatibility complex (MHC) antigen  in  liposomes has made it possible to 
directly assess the importance of class I carbohydrate moieties in T  cell recogni- 
tion  of alloantigen.  Deglycosylation of affinity-purified  H-2K  k to yield a  single 
glycan-free product  did  not alter  the  specificity,  the  magnitude,  nor  the  dose 
range  of the cytotoxic T  lymphocyte (CTL) response  to the class I antigen.  It 1386  GOLDSTEIN AND  MESCHER  BRIEF  DEFINITIVE REPORT 
can  be concluded  that  carbohydrate  moieties are not  required  to  maintain  the 
necessary  conformation  of the  MHC  protein,  nor  to  interact  with  either  the 
antigen-specific receptor or accessory proteins on precursor CTL. 
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